Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
EU's EUDAMED medical device database becomes mandatory

EU's EUDAMED medical device database becomes mandatory

Rule Changes

Four modules go live, requiring every device sold in Europe to be registered in a single public registry

November 27th, 2026: Legacy device registration deadline

Overview

Until today, registering a pacemaker, hip implant, or COVID test for sale in Europe meant filing paperwork with each of the 27 national regulators. From May 28, 2026, there is one database. Every medical device and in vitro diagnostic sold in the EU must be entered into EUDAMED, the centralized European registry, before it reaches a hospital shelf.

Four of the database's six modules switched from voluntary to mandatory: actor registration, unique device identification, notified body certificates, and market surveillance. The change closes a six-year gap between the Medical Device Regulation taking effect in 2021 and its data backbone going live, and it forces every US, Asian, and EU manufacturer to centrally publish data that was previously held in 27 separate national systems.

Why it matters

Every medical device sold in Europe, from syringes to MRI machines, must now appear in one public database — a single source of truth regulators and buyers can search.

Play on this story Voices Debate Predict Higher or Lower

Key Indicators

4 modules
Mandatory EUDAMED modules
Actor registration, UDI/device, notified bodies/certificates, and market surveillance.
6 months
Grace period for legacy devices
Devices already on the market have until 27 November 2026 to register.
€150B+
Annual EU medical device market
Approximate value of devices and IVDs sold across the EU each year.
2 modules
Modules still pending
Vigilance and clinical investigations modules remain voluntary, expected mandatory in 2027.
9 years
Time from MDR adoption to live database
MDR was adopted in 2017; the database it required became mandatory in 2026.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

Log in Sign Up

Play

Exploring all sides of a story is often best achieved with Play.

Log in to play. Track your picks, climb the leaderboards. Log in Sign Up
Predict 4 ways this could play out. Contrarian picks score more — points lock when the scenario resolves. Log in to play
Higher or Lower Two numbers from this story. Guess which is bigger. 5 rounds to set a streak. Log in to play
Timeline Five events from this story — drag them oldest to newest. Log in to play
Connections Sixteen names from the news. Find the four hidden groups of four. Log in to play

People Involved

Olivér Várhelyi
Olivér Várhelyi
Oversees DG SANTE, which signed off on the audit triggering mandatory use

Organizations Involved

European Commission
European Commission
EU Executive Body
Owns and operates EUDAMED

EU executive that wrote the Medical Device Regulation and built the database to enforce it.
Medical Device Coordination Group (MDCG)
Medical Device Coordination Group (MDCG)
EU Advisory Body
Sets EUDAMED registration guidance for member states

The expert group of national regulators that translates EUDAMED rules into operational guidance.
MedTech Europe
MedTech Europe
Industry Association
Lobbying group representing device makers selling in Europe

Trade body for medical device and IVD manufacturers operating in Europe.

Timeline

May 2017 November 2026

10 events Latest: November 27th, 2026
Tap a bar to jump to that date

  1. Legacy device registration deadline

    Latest Compliance Deadline

    Devices already on the EU market before 28 May 2026 must complete EUDAMED registration by this date.

  2. Four EUDAMED modules become mandatory

    Compliance Deadline

    Every new medical device and IVD placed on the EU market must be registered in EUDAMED before sale. Actor registration, UDI, certificates, and market surveillance modules become binding.

  3. Decision published in EU Official Journal

    Legal

    Publication starts the six-month countdown to mandatory use, ending on 28 May 2026.

  4. Commission adopts Decision 2025/2371

    Legal

    The decision formally declares the four modules functional, triggering a six-month transition period.

  5. Independent audit confirms module functionality

    Audit

    Auditors verify the actor, UDI/device, notified bodies, and market surveillance modules meet the functional specifications written into MDR Article 34.

  6. EUDAMED opens for voluntary use

    Launch

    Actor registration module goes live in voluntary mode. Other modules follow over the next two years.

  7. MDR enters full application

    Legislation

    MDR becomes binding across the EU after a one-year COVID delay, but EUDAMED is still not live.

  8. Original EUDAMED launch date missed

    Delay

    EUDAMED was scheduled to go live alongside MDR application. The Commission postpones it by two years, citing technical readiness.

  9. First EUDAMED guidance issued

    Guidance

    Commission publishes guidance on legacy device registration and EUDAMED data element timelines.

  10. EU Medical Device Regulation published

    Legislation

    Regulation 2017/745 (MDR) and 2017/746 (IVDR) published in the Official Journal. Both require a centralized database called EUDAMED.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

June 2007

REACH chemical database launch (2007)

The EU launched REACH, a centralized database requiring every chemical produced or imported above one tonne to be registered with safety data. Companies had 11 years of phased deadlines to comply, and roughly 22,000 substances were registered by the 2018 final deadline.

Then

Compliance costs ran to billions of euros. Many small chemical suppliers withdrew niche substances from the EU market rather than file the dossiers.

Now

REACH became the global template for chemical regulation, copied by South Korea, Turkey, and the UK. Centralized data also gave regulators evidence to ban substances like several phthalates.

Why this matters now

REACH is the closest EU precedent for what EUDAMED is attempting: replacing 27 national filing systems with one EU database. The pattern of small-supplier withdrawal is what device industry analysts cite when warning about Class I device exits.

September 2013 to September 2022

FDA Unique Device Identification rollout (2013-2022)

The US Food and Drug Administration required every medical device sold in America to carry a unique device identifier and be registered in the Global Unique Device Identification Database (GUDID). The rule phased in over nine years, starting with the highest-risk devices.

Then

Manufacturers spent an estimated $500 million on labeling and database integration. Hospitals reported faster recall response times once UDIs reached the point of use.

Now

GUDID became the source of truth for US device safety alerts. The UDI standard adopted by FDA is the same one EUDAMED uses, easing dual compliance for global firms.

Why this matters now

Most US medical device firms already have UDI infrastructure from the FDA rollout. EUDAMED's UDI module reuses the same identifiers, which is why the EU compliance burden falls hardest on EU-only firms and small importers, not global US companies.

May 2018

GDPR enters application (2018)

The EU General Data Protection Regulation became binding after a two-year transition. Companies handling EU personal data faced new registration, reporting, and consent requirements, regardless of where they were headquartered.

Then

Roughly 1,000 US news sites blocked EU visitors rather than comply. Major fines against Meta, Amazon, and Google followed within five years.

Now

GDPR set a global de facto standard. Brazil, California, and India modeled their privacy laws on it.

Why this matters now

GDPR is the template for how EU regulation reaches into US boardrooms. EUDAMED applies the same extraterritorial logic: if you sell into the EU, you file into the EU database, full stop.

Sources

(6)
European Commission - DG SANTE NSF International Osborne Clarke EUR-Lex - Official Journal of the European Union Morgan Lewis - As Prescribed Celegence